Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.


Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 08 11 2018
accepted: 20 06 2019
pubmed: 13 7 2019
medline: 9 11 2019
entrez: 13 7 2019
Statut: ppublish

Résumé

Patient navigation (PN) services have been shown to improve cancer screening in disparate populations. This study estimates the cost-effectiveness of implementing PN services within the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). We adapted a breast cancer simulation model to estimate a population cohort of women aged 40-64 years from the NBCCEDP through their lifetime. We incorporated their screening frequency and screening and diagnostic costs. Within the NBCCEDP, Program with PN (vs. No PN) resulted in a greater number of mammograms per woman (4.23 vs. 4.14), lower lifetime mortality from breast cancer (3.53% vs. 3.61%), and fewer missed diagnostic resolution per woman (0.017 vs. 0.025). The estimated incremental cost-effectiveness ratios for a Program with PN was $32,531 per quality-adjusted life-years relative to Program with No PN. Incorporating PN services within the NBCCEDP may be a cost-effective way of improving adherence to screening and diagnostic resolution for women who have abnormal results from screening mammography. Our study highlights the value of supportive services such as PN in improving the quality of care offered within the NBCCEDP.

Identifiants

pubmed: 31297693
doi: 10.1007/s10552-019-01200-3
pii: 10.1007/s10552-019-01200-3
pmc: PMC6737528
mid: NIHMS1049333
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

923-929

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : Centers for Disease Control and Prevention
ID : . 200-2008-27958 TO 27
Pays : United States

Références

Cancer. 2005 Aug 15;104(4):848-55
pubmed: 16010658
Cancer Causes Control. 2005 Aug;16(6):701-12
pubmed: 16049809
Stat Med. 2007 Feb 10;26(3):581-95
pubmed: 16598706
J Natl Cancer Inst Monogr. 2006;(36):2-6
pubmed: 17032887
Cancer. 2007 Jan 15;109(2 Suppl):359-67
pubmed: 17123275
J Urban Health. 2008 Jan;85(1):114-24
pubmed: 17906931
Cancer. 2008 Feb 1;112(3):626-35
pubmed: 18157831
Cancer. 2008 Oct 15;113(8):1999-2010
pubmed: 18780320
J Womens Health (Larchmt). 2009 May;18(5):677-90
pubmed: 19445616
Am J Prev Med. 2009 Sep;37(3):242-7
pubmed: 19666160
J Natl Med Assoc. 2010 Mar;102(3):206-18
pubmed: 20355350
J Gen Intern Med. 2011 Feb;26(2):116-22
pubmed: 20607432
J Community Health. 2011 Aug;36(4):675-83
pubmed: 21267639
Am J Prev Med. 2011 Apr;40(4):397-404
pubmed: 21406272
Cancer. 2011 Aug;117(15 Suppl):3539-42
pubmed: 21780088
Cancer. 2011 Aug;117(15 Suppl):3543-52
pubmed: 21780089
J Womens Health (Larchmt). 2012 Aug;21(8):821-9
pubmed: 22568434
BMC Public Health. 2012 Jul 12;12:520
pubmed: 22788387
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1629-38
pubmed: 23045537
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1645-54
pubmed: 23045539
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1655-63
pubmed: 23045540
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1691-700
pubmed: 23045544
Prev Chronic Dis. 2012;9:E159
pubmed: 23098646
J Health Care Poor Underserved. 2012 Nov;23(4 Suppl):67-76
pubmed: 23124501
J Public Health Manag Pract. 2013 Sep-Oct;19(5):461-7
pubmed: 23266756
J Gen Intern Med. 2013 Nov;28(11):1463-8
pubmed: 23686510
Health Care Manag Sci. 2014 Dec;17(4):321-30
pubmed: 24326873
Cancer. 2014 Aug 15;120 Suppl 16:2549-56
pubmed: 25099897
Health Expect. 2015 Dec;18(6):2941-50
pubmed: 25308749
J Womens Health (Larchmt). 2015 Feb;24(2):138-43
pubmed: 25522246
JAMA. 2015 Oct 20;314(15):1599-614
pubmed: 26501536
Ann Intern Med. 2016 Feb 16;164(4):279-96
pubmed: 26757170
MMWR Morb Mortal Wkly Rep. 2017 Mar 03;66(8):201-206
pubmed: 28253225
Cancer Causes Control. 2019 Aug;30(8):819-826
pubmed: 31098856

Auteurs

Benjamin T Allaire (BT)

RTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC, 27709, USA. ballaire@rti.org.

Donatus Ekweme (D)

Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA.

Thomas J Hoerger (TJ)

RTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC, 27709, USA.

Amy DeGroff (A)

Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA.

Sun Hee Rim (SH)

Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA.

Sujha Subramanian (S)

RTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC, 27709, USA.

Jacqueline W Miller (JW)

Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH